Treatment of Portal Hypertensive Gastroenteropathy

  • Kazuhiko OhoEmail author


Treatment of portal hypertensive gastropathy (PHG) essentially required reduction of portal blood pressure, for which drug therapy is recommended rather than other procedures. As PHG is a noninflammatory disease, sucralfate, H2 receptor antagonists, and proton pump inhibitors are ineffective, while propranolol is reported to be effective and has been used to reduce portal blood pressure in patients with PHG. On the other hand, the main differences of portal hypertensive colopathy and portal hypertensive enteropathy are vascular lesions, for which endoscopic treatment is the standard.


Portal hypertensive gastropathy Portal hypertensive colopathy Portal hypertensive enteropathy Propranolol Portosystemic shunt surgery Transjugular intrahepatic portosystemic shunt Argon plasma coagulation 


  1. 1.
    McCormack TT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AG, et al. Gastric lesion in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut. 1985;26:1226–32.CrossRefGoogle Scholar
  2. 2.
    Quintero E, Pique JM, Bombi JA, Bordas JM, Sentis J, Elena M, et al. Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogenI. Gastroenterology. 1987;93:1054–61.CrossRefGoogle Scholar
  3. 3.
    Lebrec D, Poynard T, Hillon P, Benhamou JP. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med. 1981;305:1371–4.CrossRefGoogle Scholar
  4. 4.
    Perez-Ayuso RM, Pique JM, Bosch J, Panes J, Gonzales A, Perez R, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet. 1991;337:1431–4.CrossRefGoogle Scholar
  5. 5.
    Sarin SK, Shahi HM, Jain M, Jain AK, Issar SK, Murthy NS. The natural history of portal hypertensive gastropathy: influence of variceal eradication. Am J Gastroenterol. 2000;95:2888–93.CrossRefGoogle Scholar
  6. 6.
    Panes J, Bordas JM, Pique JM, Garcia-Pagan JC, Feu F, Teres J, et al. Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Hepatology. 1993;17:213–8.PubMedGoogle Scholar
  7. 7.
    Shigemori H, Iwao T, Ikegami M, Toyonaga A, Tanikawa K. Effects of propranolol on gastric mucosal perfusion and serum gastrin level in cirrhotic patients with portal hypertensive gastropathy. Dig Dis Sci. 1994;39:2433–8.CrossRefGoogle Scholar
  8. 8.
    Burroughts AK, Jenkins WJ, Sherlock S, Dunk A, Walt RP, Osuafor TO, et al. Controlled trial of propranolol for the prevention of recurrent variceal haemorrhage in patients with cirrhosis. N Engl J Med. 1983;309:1539–42.CrossRefGoogle Scholar
  9. 9.
    Panes J, Pique JM, Bordas JM, Llach J, Bosch J, Teres J, et al. Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy. Hepatology. 1994;19:55–60.PubMedGoogle Scholar
  10. 10.
    Iwao T, Toyonaga A, Shigemori H, Oho K, Sumino M, Sato M, et al. Vasopressin plus oxygen vs vasopressin alone in cirrhotic patients with portal-hypertensive gastropathy: effects of gastric mucosal perfusion and oxygenation. J Gastenterol Hepatol. 1996;11:216–22.CrossRefGoogle Scholar
  11. 11.
    Panes J, Pique JM, Bordas JM, Casadevall M, Teres J, et al. Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal hypertensive gastropathy. Hepatology. 1994;20:336–41.CrossRefGoogle Scholar
  12. 12.
    Sarfeh IJ, Juler GL, Stemmer EA, Mason GR. Results of surgical management of haemorrhagic gastritis in patients with gastroesophageal varices. Surg Gynecol Obstet. 1982;155:167–70.PubMedGoogle Scholar
  13. 13.
    Resnick RH, Iber FL, Ishihara AM, Chalmers TC, Zimmerman H. A controlled study of the therapeutic portacaval shunt. Gastroenterology. 1974;67:843–57.PubMedGoogle Scholar
  14. 14.
    Rueff B, Prandi D, Degos F, Sicot J, Degos JD, Sicot C, et al. A controlled study of therapeutic portacaval shunt in cirrhosis. Lancet. 1976;1:655–9.CrossRefGoogle Scholar
  15. 15.
    Rosch J, Hanafee WN, Snow H. Work in progress. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology. 1969;92:1112–4.CrossRefGoogle Scholar
  16. 16.
    Patrick SK, Marco L, David AA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology. 2000;118:905–11.CrossRefGoogle Scholar
  17. 17.
    Ong JP, Sands M, Younossi ZM. Transjugular intrahepatic portosystemic shunts (TIPS). J Clin Gastroenterol. 2000;30:14–28.CrossRefGoogle Scholar
  18. 18.
    Cipolletta L, Bianco MA, Rotondano G, Piscopo R, Prisco A, Garofano ML. Prospective comparison of argon plasma coagulator and heater probe in the endoscopic treatment of major peptic ulcer bleeding. Gastrointest Endosc. 1998;48:191–5.CrossRefGoogle Scholar
  19. 19.
    Galcia N, Sanyal AJ. Portal hypertensive gastropathy and gastric antral vascular ectasia. Curr Treat Options Gastroenterol. 2001;4:163–71.CrossRefGoogle Scholar
  20. 20.
    Ripoll C, Garcia-Tsao G. Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension. Curr Treat Options Gastroenterol. 2007;10:483–94.CrossRefGoogle Scholar
  21. 21.
    Naveau S, Aubert A, Poynard T, Chaput JC. Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium-YAG laser photocoagulation. Dig Dis Sci. 1990;35:821–6.CrossRefGoogle Scholar
  22. 22.
    Balzer C, Lotterer E, Kleber G, Fleig WE. Transjugular intrahepatic portosystemic shunt for bleeding angiodysplasia-like lesions in portal-hypertensive colopathy. Gastroenterology. 1998;115:167–72.CrossRefGoogle Scholar
  23. 23.
    Johansen K, Bardin J, Orloff MJ. Massive bleeding from hemorrhoidal varices in portal hypertension. JAMA. 1980;224:2084–5.CrossRefGoogle Scholar
  24. 24.
    Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996;11:51–8.CrossRefGoogle Scholar
  25. 25.
    Chen WC, Hou MC, Lin HC, Chang FY, Lee SD. An endoscopic injection with N-butyl-2-cyanoacrylate used for colonic variceal bleeding: a case report and review of the literature. Am J Gastroenterol. 2000;95:540–2.CrossRefGoogle Scholar
  26. 26.
    Haruta I, Isobe Y, Ueno E, Toda J, Mitsunaga A, Noguchi S, et al. Balloon-occluded retrograde transvenous obliteration (BRTO), a promising nonsurgical therapy for ectopic varices: a case report of successful treatment of duodenal varices by BRTO. Am J Gastroenterol. 1996;91:2594–7.PubMedGoogle Scholar
  27. 27.
    Katz JA, Bubin RA, Cope C, Holland G, Brass CA. Recurrent bleeding from anorectal varices: successful treatment with a transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 1993;88:1104–7.PubMedGoogle Scholar
  28. 28.
    Fantin AC, Zala G, Risti B, Debatin JF, Schöpke W, Meyenberger C. Bleeding anorectal varices: successful treatment with a transjugular intrahepatic portosystemic shunting. Gut. 1996;38:932–5.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Kurume University School of MedicineFukuokaJapan
  2. 2.Department of Gastroenterology and HepatologyYanagawa HospitalFukuokaJapan

Personalised recommendations